NCT06792760

Brief Summary

Functional movement disorder (FMD) is a common source of neurological disability that imposes a significant financial burden on healthcare systems. However, the heterogeneous manifestations of FMD and numerous associated non-motor symptoms, often fluctuating over time, present a challenge for developing effective treatment pathways. Although increasing evidence supports the efficacy of physiotherapy for FMD, the lack of predictors of treatment outcomes remains a significant obstacle to effectively managing FMD. The main hypothesis of this project is that abnormalities in interoceptive processing are responsible for variability in motor and non-motor symptoms and response to physiotherapy. Interoception describes the afferent signalling, central processing, and mental representation of internal bodily signals. We hypothesize that worse performance on interoceptive tests will be associated with greater severity of motor and non-motor symptoms and worse quality of life. We also expect that patients with worse interoceptive performance and associated non-motor symptoms such as pain will particularly benefit from treatment techniques modulating interoception, such as specific breathing techniques. Therefore, to test our hypotheses, in this project, we will study interoceptive and attentional abnormalities of FMD and identify predictors of the effect of physiotherapy and interoceptive respiratory training.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Apr 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Apr 2025Dec 2028

First Submitted

Initial submission to the registry

January 20, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 27, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

July 23, 2025

Status Verified

July 1, 2025

Enrollment Period

2.7 years

First QC Date

January 20, 2025

Last Update Submit

July 19, 2025

Conditions

Keywords

Functional Movement DisorderInteroceptionPhysiotherapyBreathing techniquesInteroceptive trainingAttention

Outcome Measures

Primary Outcomes (1)

  • Clinical Global Impressions (CGI) scale - patient rated

    Clinical Global Impressions (CGI-I) scale, patient-rated, is a 5-point scale evaluating improvement from 'very much improved' to 'very much worse'. 'Very much improved' indicates a better outcome.

    pre-treatment (baseline), one week after the last intervention, 6-month follow-up, 12-month follow-up

Secondary Outcomes (4)

  • Clinical Global Impressions (CGI) - clinician rated scale

    one week after the last intervention, 6-month follow-up, 12-month follow-up

  • 36-item Short Form Survey (SF-36)

    pre-treatment (baseline), one week after the last intervention, 6-month follow-up, 12-month follow-up

  • Fibromyalgia Survey Questionnaire

    pre-treatment (baseline), one week after the last intervention, 6-month follow-up, 12-month follow-up

  • The Simplified Functional Movement Disorders Rating Scale (S-FMDRS)

    pre-treatment (baseline), one week after the last intervention, 6-month follow-up, 12-month follow-up

Other Outcomes (16)

  • Work and Social Adjusment Scale (WSAS)

    pre-treatment (baseline), 6-month follow-up, 12-month follow-up

  • Illness belief and understanding and confidence in the diagnosis

    pre-treatment (baseline)

  • Readiness for treatment

    pre-treatment (baseline)

  • +13 more other outcomes

Study Arms (2)

FMD specific physiotherapy

ACTIVE COMPARATOR

This arm will receive specific physiotherapy treatment for people with Functional Movement Disorder based on published recommendations.

Other: Physiotherapy

FMD specific physiotherapy + specific breathing techniques

EXPERIMENTAL

This arm will receive specific physiotherapy treatment for people with Functional Movement Disorder based on published recommendations + specific breathing exercises as interoceptive training

Other: PhysiotherapyOther: Specific Breathing Techniques

Interventions

The intervention will consist of 10 individual physiotherapy sessions delivered by a single physiotherapist trained in FMD. The physiotherapy programme will include education, movement retraining and a self-management plan.

FMD specific physiotherapyFMD specific physiotherapy + specific breathing techniques

The intervention will include education and training in specific breathing techniques, which will be exercised by the patient as a self-management plan for over 5-10 minutes daily.

FMD specific physiotherapy + specific breathing techniques

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • clinically established diagnosis of Functional Movement Disorder according to Gupta and Lang criteria

You may not qualify if:

  • age \<18 years
  • inability to complete questionnaires because of language difficulties
  • severe learning disabilities or cognitive impairment
  • major psychiatric or organic neurological comorbidity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General University Hospital in Prague

Prague, Czech Republic, 12800, Czechia

Location

MeSH Terms

Conditions

Conversion Disorder

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Somatoform DisordersMental Disorders

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Tereza Serranová, MD, PhD

    General University Hospital in Prague, Neurology department, Prague, Czech Republic, 12800

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Pragmatic, prospective, single-blind, interventional parallel arm clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2025

First Posted

January 27, 2025

Study Start

April 1, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2028

Last Updated

July 23, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
"Beginning 1 year after publication with no end date"
Access Criteria
Anonymized data will be shared with other researchers based on reasonable request.

Locations